Inter‐organ communication: a gatekeeper for metabolic health DOI Creative Commons
Judit Castillo‐Armengol, Lluís Fajas, Isabel C. López‐Mejía

et al.

EMBO Reports, Journal Year: 2019, Volume and Issue: 20(9)

Published: Aug. 19, 2019

Review19 August 2019Open Access Inter-organ communication: a gatekeeper for metabolic health Judit Castillo-Armengol Center Integrative Genomics, University of Lausanne, Switzerland Search more papers by this author Lluis Fajas Corresponding Author [email protected] orcid.org/0000-0002-1283-9503 Isabel C Lopez-Mejia Information Castillo-Armengol1, *,1 and 1Center *Corresponding author. Tel: +41 21 692 41 11; E-mail: 4146; EMBO Reports (2019)20:e47903https://doi.org/10.15252/embr.201947903 See the Glossary abbreviations used in article. PDFDownload PDF article text main figures. ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinked InMendeleyWechatReddit Figures & Info Abstract Multidirectional interactions between organs periphery central nervous system have evolved concomitantly with multicellular organisms maintain whole-body energy homeostasis ensure organism's adaptation external cues. These are altered pathological conditions such as obesity type 2 diabetes. Bioactive peptides proteins, hormones cytokines, produced both peripheral system, key messengers inter-organ communication. Despite early discovery first than 100 years ago, recent studies taking advantage novel technologies shed light on multiple ways cells body communicate balance. This review briefly summarizes well-established concepts focuses advances describing how specific proteins mediate crosstalk gut, brain, other order homeostasis. Additionally, outlines improved knowledge about these networks is helping us redefine therapeutic strategies an effort promote healthy living fight disorders diseases. ACC Acetyl-CoA Carboxylase ADBR3 β3-adrenergic receptor AdipoR1/2 Adiponectin receptors AgRP Agouti-related peptide AKT Protein kinase B (PKB), also known AMPK AMP-activated protein kinase. Anorexigenic Hormone(s) or compound(s) resulting decreased appetite. ARC Arcuate nucleus ATP Adenosine trisphosphate Autocrine signaling method which cell releases molecule that will bind exert its action same cell. BAs Bile acids BAT Brown adipose tissue BMP8b Bone morphogenetic 8b cAMP Cyclic adenosine monophosphate CCK Cholecystokinin CNS Central CSF Cerebrospinal fluid CTSB Cathepsin CX43 Connexin 43 CXCL14 C-X-C motif chemokine ligand-14 Cytokines class small can be broad variety act molecules. In circulation, cytokines usually found smaller concentration hormones. DIO2 Type iodothyronine deiodinase DIO Diet-induced DMH Dorsomedial hypothalamus Endocrine released into bloodstream before binding exerting distant cells. Exosomes extracellular vesicles from constitute intercellular communication transmission macromolecules may contain cargo molecules like lipids, DNA, mRNAs miRNAs. FBN1 Profibrillin gene. precursor asprosin. FGF19 Fibroblast growth factor 19 FGF21 FNDC5 Fibronectin III domain-containing 5. irisin. FoxO1 Forkhead box O1 GH Growth hormone GHSR secretagogue GIP Glucose-dependent insulinotropic GLP-1 Glucagon-like 1 GLP-1R GLUT2 Glucose transporter HFD High-fat diet Hormones secreted given trigger integrative responses stimuli. IL-1Ra Interleukin antagonist IL-6 Interleukine 6 IRS-2 Insulin substrate JAK2 Janus Lcn5 Lipocalin 5 LEAP2 Liver-expressed antimicrobial LepRb Leptin b LHA Lateral hypothalamic area MAPK Mitogen-activating MCP1 Monocyte chemotactic Metrnl Meteorin-like mTOR Mammalian target rapamycin NE Norepinephrine NPY Neuropeptide Y Orexigenic increased Paracrine nearby PGC1α Peroxisome proliferator-activated gamma coactivator 1-α PKA A PM20D1 Peptidase M20 POA Preoptic POMC Pro-opiomelanocortin PSNS Parasympathetic system—The part autonomic involved regulation numerous basic functions. It stimulates “feed breed” “rest digest” functions antagonistic SNS. RBP4 Retinol 4 RPA Raphe pallidus SctR Secretin SNS Sympathetic “fight flight” responses. rapid urgent reactions PSNS. STAT3 Signal transducer activator transcription 3 T2D diabetes T3, T4 Thyroid TCPTP T-cell tyrosine phosphatase TGFβ Transforming β TGR5 BA TG Triglycerides TNF-α Tumor necrosis factor-α TSH Thyroid-stimulating UCP1 Uncoupling VAN Vagal afferent neurons VMH Ventromedial WAT White Introduction adapt conditions, different tissues each via signals. Peripheral produce plethora bioactive molecules, including (from Greek horme means impulsion), autocrine, paracrine, endocrine manner (see Glossary). immune namely 1, participate Alternatively, coordinates metabolism not only production neurohormones locally, but direct innervation 2-5. Indeed, sympathetic parasympathetic fibers innervating express enzymes crucial biosynthesis transport (neurotransmitters neuropeptides) necessary tissue-specific response Early research 19th century, most notably Claude Bernard, suggested involving chemical ensures 6. The term “hormone” was 1905 British physiologist Ernest Stalling describe gut secretin, described just prior 7, 8. Carl Ferdinand Cori Gerty then cycle lactate anaerobic glycolysis muscles recycled liver converted glucose. turn, glucose returned muscle where it metabolized 9. “Cori cycle” one examples efficient organs, facilitate demands. Key hormones, pancreatic insulin glucagon, were successfully identified, synthesized, therapy course 20th century. identification has exponentially years, giving rise terms hepatokines 10, myokines 11, adipokines 12, batokines 13, liver, muscle, white (WAT), brown (BAT), respectively. secretion varies according status body. They respond instance fasting feeding cycles 14, circadian rhythm 15, cold exposure 16, exercise17, thus participating adaptive ensuring flexibility. pathologic example, related dysfunction, obesity. As such, alterations currently contribute spectrum obesity-associated pathologies. Therefore, pharmacological interventions modify hormones/cytokines, directly delivering recombinant being explored promising approaches treat wide obesity-related review, we summarize mechanisms focus highlighted importance WAT, BAT, pancreas, maintenance fitness. role been recently discussed elsewhere 18 review. further concludes citing additional actors mediators states our opinion future directions field. control fasting/feeding section, discuss organismal consumption food (Fig 1), followed compensatory engaged low state 2). Figure 1. under conditionsFood ingestion several GLP-1, secretin LEAP2. signal brain reduce intake. intestine reduces bile acid (BA) synthesis. stimulate (and glucagon) pancreas. glycogen uptake decrease increase lipogenesis circulating triglycerides (TGs) WAT. Leptin, adipocytes, repress Moreover, lipolysis liver. Download figure PowerPoint 2. conditionsGhrelin conditions. targets Pancreatic glucagon ghrelin, blood levels. Glucagon hepatic gluconeogenesis glycogenolysis, well lipolysis. Ghrelin adiposity increasing lipid synthesis reducing fatty (FA) oxidation. Fasting asprosin adiponectin through expenditure Asprosin gluconeogenesis, whereas increases FA Increased levels physiological meal initiates triggered presence nutrients. Enteroendocrine sense nutrients intestinal lumen cholecystokinin (CCK), incretins; glucose-dependent (GIP); glucagon-like (GLP-1) 19, 20. Gut play their acting circulation activating paracrine manner. major gut-derived vagal (VANs) 21. Endogenous acts VANs inhibit actions modulated fact (GLP-1R) internalized upon translocate plasma membrane after when ghrelin low. work synergistically potentiate glucose-stimulated β-cells inhibits α-cells. exocrine pancreas activity proper environment digestion absorption intake activation (SctR) sensory nerves melanocortin 22, 23. After postprandial initiated changes nutrients, mainly (TG), engage system. An sensed GLUT2. sensing leads β-cell ultimately 24. parallel, release α-cells 25, 26. insulin-sensitive induce utilization storage preventing hyperglycemia. By regulates behavior modifies tissues, cognitive 27-31. promotes metabolization hexokinases de novo lipogenesis, while decreasing production. Intact is, however, dispensable repression absence 32, 33, highlighting 34. triggers promoting externalization GLUT4 expression specifically glucose-derived glycerol serves building blocks TGs; TGs serve fuel stock scarcity. avoid excessive intake, adiposity, unnecessary storage, deleterious effects organism, capability hormone-producing organ. adipocytes proportionally stores 35-37. widely highly expresses long form leptin (LepRb). signals constant stock. suppresses adrenal corticosteroids 38, 39. activate oxidation AMPK-dependent 40. Whether process indirect remains unclear 41. (BAs) (Fgf15 mice) ileum. induces feedback 42. repressing 43, 44, independently insulin. Importantly, Fgf15 modulate 45 46. More recently, liver-expressed (LEAP2), initially liver-produced peptide, peptide. fed state, suppressed fasting. reported endogenous receptor, (GHSR). fully blunt (GH) 47. study adds growing list connect control. Thus far, body, state. Upon meal, aforementioned orchestrate coordinated substrates, initiating negative loop satiety “positive balance” 1). When low, lack stomach, glucose, replenish alternative substrates keep functioning. gastric epithelium stomach empty. Plasma concentrations high during 48. potent inducer 49, now GHSR. exerts orexigenic centrally arcuate (ARC) triggering agouti-related (AgRP) neuropeptide (NPY) However, exact mechanism plays unclear. To date, three hypotheses follows: (i) VANs, (ii) synthesized locally feeding, (iii) crosses blood–brain barrier activates 50. attenuates intracellular localization counteracting 51. secretion, carbohydrate use, stimulating synthesis, 50, 52. shown require intact 53. Adipokine modified rapidly reduction switch “fasted state” “fed 54. contrast leptin, at least cerebrospinal (CSF) 55, 56. Overall, inversely proportional correlate Numerous (adiponectin essentially ubiquitous). ARC, expenditure, suggesting anorexigenic sensitivity independent mechanisms: phosphorylation, AMPK-independent involves ceramide 57, IL-6-dependent upregulation (IRS-2) 58. 39 remain debated Asprosin, fasting-induced adipokine production, identified 59. C-terminal cleavage product profibrillin (FBN1 gene). encoded last two exons mice. release, without catecholamines, glucocorticoids. β-adrenergic (CNS) 60. (FGF21) hepatokine 61 62, 63. turn lipolysis, ketogenesis, availability brain. worth noting knockout mice exhibit lower glycemia fasted ketone bodies 64, 65. Fasting-induced hypoglycemia results stimulated glucagon. Hypoglycemia GLUT2-positive input 66. pathway mobilization (glycogenolysis) and, if prolonged, (gluconeogenesis), glycogenesis. preserve free glycerol. Glycerol transported oxidized gluconeogenesis. Albumin-bound tissues. promoted (SNS) innervation. norepinephrine (NE) similar tone could 67, 68. Notably, depots sparser 69. denser regions subcutaneous (or inguinal) 70, 71. cell-to-cell connexin (CX43) containing gap junctions essential disseminating adrenergic 72. situations deprivation counter regulatory maintains enough prevent function, energy-providing available all organs. accompanied overall energy. non-shivering thermogenesis temperature, developed homeotherms. Mammals specialized heat 73. especially abundant hibernating mammals 74, adult humans 75. stress summarized Fig 3. exposureCold stimuli, skin, thermoregulatory secrete orexin BMP8B thermogenesis. responsible local BAT. hypothalamic–pituitary–thyroid axis activated thyroid (T3 T4) Cold shivering myokine Irisin If sustained over time, undergoes browning process. addition, cold-dependent Finally, WAT; Cold-induced organ integrates CNS. terminals processed preoptic (POA), center 76. transduction regions, lateral (LHA), ventromedial (VMH), dorsomedial (DMH), (ARC). Orexin producing located LHA, named neurons, administration therefore 77. infusion firing 78. Both interact Hypothalamic bone (BMP8b) enhances projections 79. Interestingly, 80. Several linked cold. For stimulation thermogenic rats 81. Similarly, incretin 82. Outflow areas premotor stem region raphe (RPA). broadly present within parenchyma 83. hydroxylase, enzyme catecholamine 84. catecholamine-responsive tissue. constituted droplets number mitochondria. (ADBR3) cAMP/PKA pathway, uncoupling (UCP1). Free acids, activators uncouple mitochondrial respiration 73, 85. Apart 86. T3 synthetized gland pituitary thyroid-stimulating (TSH) 87. access transporters. active (DIO2) compensating gland-secreted 88.

Language: Английский

Microbial regulation of organismal energy homeostasis DOI
Patrice D. Cani, Matthias Van Hul, Charlotte Lefort

et al.

Nature Metabolism, Journal Year: 2018, Volume and Issue: 1(1), P. 34 - 46

Published: Dec. 30, 2018

Language: Английский

Citations

454

Bile Acid Metabolism in Liver Pathobiology DOI
John Y.L. Chiang, Jessica M. Ferrell

Gene Expression, Journal Year: 2018, Volume and Issue: 18(2), P. 71 - 87

Published: Jan. 12, 2018

Bile acids facilitate intestinal nutrient absorption and biliary cholesterol secretion to maintain bile acid homeostasis, which is essential for protecting liver other tissues cells from toxicity. metabolism tightly regulated by synthesis in the biotransformation intestine. are endogenous ligands that activate a complex network of nuclear receptor farnesoid X membrane G protein-coupled receptor-1 regulate hepatic lipid glucose metabolic homeostasis energy metabolism. The gut-to-liver axis plays critical role regulation enterohepatic circulation acids, pool size, composition. control gut bacteria overgrowth, metabolize host Alteration high-fat diets, sleep disruption, alcohol, drugs reshapes microbiome causes dysbiosis, obesity, disorders. Gender differences metabolism, FXR signaling, microbiota have been linked higher prevalence fatty disease hepatocellular carcinoma males. contributes cholestatic diseases, inflammatory diseases digestive system, diabetes. acid-activated receptors potential therapeutic targets developing treat

Language: Английский

Citations

421

Metabolic-associated fatty liver disease and lipoprotein metabolism DOI Creative Commons
Jöerg Heeren, Ludger Scheja

Molecular Metabolism, Journal Year: 2021, Volume and Issue: 50, P. 101238 - 101238

Published: April 20, 2021

Non-alcoholic fatty liver disease, or as recently proposed 'metabolic-associated disease' (MAFLD), is characterized by pathological accumulation of triglycerides and other lipids in hepatocytes. This common disease can progress from simple steatosis to steatohepatitis, eventually end-stage diseases. MAFLD closely related disturbances systemic energy metabolism, including insulin resistance atherogenic dyslipidemia. The the central organ lipid metabolism secreting very low density lipoproteins (VLDL) and, on hand, internalizing acids lipoproteins. review article discusses recent research addressing hepatic synthesis, VLDL production, lipoprotein internalization well exchange between adipose tissue context MAFLD. Liver triggered excessive triglyceride synthesis utilizing derived white (WAT), de novo lipogenesis (DNL) endocytosed remnants triglyceride-rich In consequence high content, secretion enhanced, which primary cause complex dyslipidemia typical for subjects with Interventions reducing secretory capacity attenuate while they exacerbate MAFLD, indicating that balance storage versus hepatocytes a critical parameter determining outcome. Proof concept studies have shown promoting combustion tissues reduces load thus ameliorates Moreover, hepatocellular DNL WAT-derived be targeted treat However, more needed understand how individual transporters, enzymes, their isoforms affect vivo, whether these two aspects selectively treated. Processing cholesterol-enriched appears less important steatosis. It may, however, modulate inflammation consequently progression.

Language: Английский

Citations

409

Diet, Gut Microbiota, and Obesity: Links with Host Genetics and Epigenetics and Potential Applications DOI Creative Commons
Amanda Cuevas‐Sierra, Omar Ramos-López, José Ignacio Riezu‐Boj

et al.

Advances in Nutrition, Journal Year: 2018, Volume and Issue: 10, P. S17 - S30

Published: Oct. 30, 2018

Language: Английский

Citations

398

Bile acids in glucose metabolism in health and disease DOI Creative Commons
Hagit Shapiro, Aleksandra A. Kolodziejczyk, Daniel Halstuch

et al.

The Journal of Experimental Medicine, Journal Year: 2018, Volume and Issue: 215(2), P. 383 - 396

Published: Jan. 16, 2018

Bile acids (BAs) are cholesterol-derived metabolites that facilitate the intestinal absorption and transport of dietary lipids. Recently, BAs also emerged as pivotal signaling molecules controlling glucose, lipid, energy metabolism by binding to nuclear hormone farnesoid X receptor (FXR) Takeda G protein 5 (TGR5) in multiple organs, leading regulation incretin secretion, hepatic gluconeogenesis, glycogen synthesis, expenditure, inflammation, gut microbiome configuration. Alterations BA associated with obesity type 2 diabetes mellitus (T2DM), whereas treatment T2DM patients sequestrants, or bariatric surgery morbidly obese patients, results a significant improvement glycemic response is changes profile signaling. Herein, we review roles glucose health disease; highlight limitations, unknowns, challenges understanding impact on response; discuss how this knowledge may be harnessed develop innovative therapeutic approaches for hyperglycemia diabetes.

Language: Английский

Citations

366

The cellular and functional complexity of thermogenic fat DOI
Paul Cohen, Shingo Kajimura

Nature Reviews Molecular Cell Biology, Journal Year: 2021, Volume and Issue: 22(6), P. 393 - 409

Published: March 23, 2021

Language: Английский

Citations

351

The role of the gut microbiome and its metabolites in metabolic diseases DOI Creative Commons
Jiayu Wu, Kai Wang, Xuemei Wang

et al.

Protein & Cell, Journal Year: 2020, Volume and Issue: 12(5), P. 360 - 373

Published: Dec. 21, 2020

Abstract It is well known that an unhealthy lifestyle a major risk factor for metabolic diseases, while in recent years, accumulating evidence has demonstrated the gut microbiome and its metabolites also play crucial role onset development of many including obesity, type 2 diabetes, nonalcoholic fatty liver disease, cardiovascular disease so on. Numerous microorganisms dwell gastrointestinal tract, which key interface energy acquisition can metabolize dietary nutrients into bioactive substances, thus acting as link between host. The shaped by host genetics, immune responses factors. potential determines significance health diseases. Therefore, targeting relevant pathways would be effective therapeutic treatments diseases near future. This review will summarize information about organism metabolism relationship microbiome-derived pathogenesis Furthermore, advances improving regulating discussed.

Language: Английский

Citations

334

Gut microbiota, a new frontier to understand traditional Chinese medicines DOI
Wuwen Feng, Hui Ao, Cheng Peng

et al.

Pharmacological Research, Journal Year: 2019, Volume and Issue: 142, P. 176 - 191

Published: Feb. 25, 2019

Language: Английский

Citations

306

Bile acid receptors FXR and TGR5 signaling in fatty liver diseases and therapy DOI Open Access
John Y.L. Chiang, Jessica M. Ferrell

AJP Gastrointestinal and Liver Physiology, Journal Year: 2020, Volume and Issue: 318(3), P. G554 - G573

Published: Jan. 27, 2020

Bile acid synthesis is the most significant pathway for catabolism of cholesterol and maintenance whole body homeostasis. acids are physiological detergents that absorb, distribute, metabolize, excrete nutrients, drugs, xenobiotics. also signal molecules metabolic integrators activate nuclear farnesoid X receptor (FXR) membrane Takeda G protein-coupled 5 (TGR5; i.e., bile 1) to regulate glucose, lipid, energy metabolism. The gut-to-liver axis plays a critical role in transformation primary secondary acids, regulation maintain composition within pool, homeostasis prevent hyperglycemia, dyslipidemia, obesity, diabetes. High-fat high-calorie diets, dysbiosis, alcohol, disruption sleep circadian rhythms cause diseases, including alcoholic nonalcoholic fatty liver diabetes, cardiovascular disease. acid-based drugs target receptors being developed treatment diseases liver.

Language: Английский

Citations

304

Molecular physiology of bile acid signaling in health, disease, and aging DOI
Alessia Perino, Hadrien Demagny, Laura A. Velázquez‐Villegas

et al.

Physiological Reviews, Journal Year: 2020, Volume and Issue: 101(2), P. 683 - 731

Published: Aug. 13, 2020

Several diseases and conditions have been associated with an uncontrolled rise in bile acid (BA) concentrations. This is often the case when tight feedback regulation of BA synthesis compromised to point that BAs become detrimental. their cognate receptors, farnesoid X receptor (FXR) Takeda G-protein 5 (TGR5), however, exert many beneficial roles as they enable tissues adapt environmental, nutritional, physiological cues. Over last two decades, mimetics targeting FXR, TGR5, or both, proven be efficacious alleviating chronic metabolic inflammatory disorders, such obesity, Type 2 diabetes (T2D), atherosclerosis non-alcoholic steatohepatitis (NASH). While several aspects signaling are still poorly understood, first therapeutics FXR making way into clinic treat liver diseases, primary biliary cholangitis (PBC) NASH. Drugs may, hence, a bright future continuing efforts on studying impact changing pathways humans will translate our emerging knowledge physiology model organisms clinical benefits.

Language: Английский

Citations

304